ShRNA and Single Genetic Modification May Lower CAR-T Manufacturing Costs
Cell therapy developer Celyad Oncology is using short-hairpin RNA (shRNA) to create T cells that can be used as an “off-the-shelf” allogeneic therapy for cancer patients. They are also using the technology to help...
eGenesis Appoints Veteran Biotechnology Development Executive, Michael Curtis, Ph.D., as President of Research &...
CAMBRIDGE, Mass., Sept. 01, 2020 (GLOBE NEWSWIRE) -- eGenesis, a biotechnology company using breakthrough gene editing technologies for the development of safe and effective human-compatible organs, tissues, and cells to address the global organ...
Cold Cases Heat Up with New Forensic DNA Methods
In April 2017, a man set out from New York to hike the Appalachian Trail. For 15 months, he made his way south, stopping along the way to socialize with fellow hikers. Then, in...
New EU research project seeks to kickstart the development of “Organoid Cell Atlas”
Reviewed by Emily Henderson, B.Sc.Aug 31 2020
HCA|Organoid is a new EU research project that combines single-cell profiling and organoid technology to validate organoids as faithful models of human biology. The project seeks to kickstart...
After Years of Neglect, Algae Biotechnology Makes a… – Labiotech.eu
Despite their ability to create matter out of thin air, algae and cyanobacteria have long been neglected by the biotech industry. Recently, however, they have started to gain traction in new market niches.
In the...
Agricultural Biotechnology Market Show Steady Growth: Study – The News Brok
This report presents the worldwide Agricultural Biotechnology market size (value, production and consumption), splits the breakdown (data status 2018 and forecast to 2025), by manufacturers, region, type and application.
This study also analyzes the market...
Study may help explain the symptoms and organs involved with SARS-CoV-2 infection
Reviewed by Emily Henderson, B.Sc.Aug 28 2020
A study of a gateway receptor for SARS-CoV-2 led by Walter Lukiw, PhD, Professor of Neuroscience, Neurology and Ophthalmology at LSU Health New Orleans' Neuroscience Center of Excellence...
The Future of CRISPR Cell Therapies is GMP
/* custom css */
.td_uid_1_5f49e5fd9b6be_rand { min-height: 0; }
/* custom css */
.td_uid_2_5f49e5fd9b87c_rand { vertical-align: baseline; }
REGISTER NOW
jQuery(window).load(function () { jQuery('body').find('#td_uid_1_5f49e5fd9b6b7 .td-element-style').each(function (index, element) { jQuery(element).css('opacity', 1); return; }); }); ...
BIOTECHNOLOGY REAGENTS MARKET IS PROSPERING GLOBALLY 2020-2026 || LEADING PLAYERS – F. HOFFMANN-LA ROCHE...
Research and analysis about the key developments in the market, major competitors and detailed competitor analysis covered in this Biotechnology Reagents Market report helps businesses imagine the bigger picture of the market place which...
Inhibiting STING activation could be new therapeutic strategy to treat ALS and FTD
Alberto Yáñez Boyer, Ramón y Cajal researcher at BIOTECMED (Interdisciplinary Research Structure in Biotechnology and Biomedicine) and the Department of Microbiology and Ecology at the University of Valencia (UV), participates in a study on...
